Shelby Research

SLE CLINICAL TRIAL

Are you Suffering from Lupus?

You are not alone.

Over 1.5 million Americans have Lupus, and approximately 5 million others throughout the world.¹
We are looking to see if an investigational study drug for Lupus in adults works to help treat the signs and symptoms of the condition.

 
 

GET STARTED-SEE IF YOU QUALIFY:

*No health insurance is required to participate All study-related care will be provided by a team of medical staff at no cost to you. Volunteers who take part in the study may receive compensation for their time and travel The SLEek Study will include about 325 patients with a diagnosis of Systemic Lupus Erythematosus (SLE) and will be conducted at 140 study sites worldwide. All study-related care will be provided by specialty physicians and a dedicated study team. If you qualify for the study, you will visit a study clinic in your area approximately 15 times over 48 weeks. The study will be evaluating the effectiveness of an investigational study drug for SLE. Volunteers who qualify to take part in the study may receive compensation for time and travel expenses. If you are between the ages 18 and 65 and have been diagnosed with Systemic Lupus Erythematosus (SLE) you may be able to participate. All study-related care is provided at no cost. You do not need health insurance to participate. Volunteers who take part in the study may be eligible to receive compensation for their time and travel. Participants will receive all study-related care from a team of medical professionals at no cost. The study will require approximately 15 visits over 48 weeks to a research center in your area.

Who can take part in the SLEek Study?

You may be able to take part in the study if you:

  • have a diagnosis of Systemic Lupus Erythematosus (SLE)

  • are between the ages of 18 and 65

  • have had a diagnosis of SLE for at least six months

*All study-related care will be provided by a team of medical professionals.

SEE IF YOU QUALIFY

Volunteers who take part in the study may be eligible to receive compensation for their time and travel.

[About Systemic Lupus Erythematosus]

Systemic Lupus Erythematosus (SLE) is an autoimmune disease that causes the body to mistakenly attack healthy tissue.  SLE typically affects the skin, joints, kidneys and brain.

The cause of SLE is not well-known, however women are more likely to be affected than men. SLE can occur at any age. There are factors that may be linked to Systemic Lupus Erythematosus such as:

  • Genetic

  • Environmental

  • Hormonal

Almost everyone with SLE experiences joint pain and swelling, but other symptoms may vary person to person.  It is common for Systemic Lupus Erythematosus to affect the joints of the hands, knees and wrists.² Other symptoms may include:

  • Fatigue

  • Fever

  • Hair Loss

  • Weight Loss

  • Skin Rashes

  • Photosensitivity (in SLE, photosensitivity refers to developing new or larger rashes when exposed to the sun)

Although there is no cure for SLE, the goal of treatment is to ease symptoms. Treatment plans will vary depending on the individual's case. The SLEek Study is investigating a new medication to help treat the signs and symptoms of the disease.

References:
[1] https://www.lupus.org/resources/lupus-facts-and-statistics
[2] https://medlineplus.gov/ency/article/000435.htm


For more information visit our the clinical trial page